INDO US BIOTECH
Back to Balance Sheet
|
INDO US BIOTECH Last 5 Year Capital Work in Progress History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Capital Work in Progress | - | ₹3.78 Cr | ₹1.37 Cr | ₹2.33 Cr | ₹1.99 Cr |
What is the latest Capital Work in Progress ratio of INDO US BIOTECH ?
| Year | Capital Work in Progress |
|---|---|
| Mar2025 | - |
| Mar2024 | ₹3.78 Cr |
| Mar2023 | ₹1.37 Cr |
| Mar2022 | ₹2.33 Cr |
| Mar2021 | ₹1.99 Cr |
How is Capital Work in Progress of INDO US BIOTECH Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2025 | - | -100.00 | |
| Mar2024 | ₹3.78 Cr | 176.37 | |
| Mar2023 | ₹1.37 Cr | -41.20 | |
| Mar2022 | ₹2.33 Cr | 17.07 | |
| Mar2021 | ₹1.99 Cr | - | |
Compare Capital Work in Progress of peers of INDO US BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDO US BIOTECH | ₹247.6 Cr | -1.5% | 1.4% | -66.9% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹13,289.5 Cr | 2.1% | -0.7% | -19.6% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,789.5 Cr | -4.6% | -8.7% | 5.5% | Stock Analytics | |
| VENKYS (INDIA) | ₹1,979.8 Cr | -1.4% | 4.2% | -23.9% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,055.4 Cr | -0.3% | -11.4% | -37.7% | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹484.1 Cr | -2.5% | -1% | 19% | Stock Analytics | |
INDO US BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDO US BIOTECH | -1.5% |
1.4% |
-66.9% |
| SENSEX | -0.4% |
-0.3% |
3.9% |
You may also like the below Video Courses